Ayah Matar

Ayah Matar

Auto-generated profile, based on publicly available information

Ayah Matar

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2024 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
WIWillian Ferreira Igi
Willian Ferreira Igi
VOVictor Lira de Oliveira
Victor Lira de Oliveira
AMAyah Matar
Ayah Matar
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura
The treatment of obesity and its comorbidities ranges from clinical management involving lifestyle changes and medications to bariat­ric and metabolic surgery. Various endoscopic bariatric and metabolic therapies recently emerged to address an important therapeutic gap by offering a less invasive alternative to surgery that is more effective than conservative therapies. This article compre­hensively reviews the technical aspects, mechanism of action, outcomes, and future perspectives of one of the most promising endoscopic bariatric and metabolic therapies, named duodenojejunal bypass liner. The duodenojejunal bypass liner mimics the mechanism of Roux-en-Y gastric bypass by preventing food contact with the duodenum and proximal jejunum, thereby initiating a series of hormonal changes that lead to delayed gastric emptying and malabsorptive effects. These physiological changes result in significant weight loss and improved metabolic control, leading to better glycemic levels, preventing dyslipidemia and non-alcoholic fatty liver disease, and mitigating cardiovascular risk. However, concern ex­ists regarding the safety profile of this device due to the reported high rates of severe adverse events, particularly liver abscesses. Ongo­ing technical changes aiming to reduce adverse events are being evaluated in clinical trials and may provide more reliable data to sup­port its routine use in clinical practice.

21 February 2025 in VideoGIE
Verified
Journal Article
Open access
AMAyah Matar
Ayah Matar
GCGregory Charville
Gregory Charville
MLMaggie Lam
Maggie Lam
SESamer Eldika
Samer Eldika
The incidental diagnosis of pancreatic cystic lesions has been increasing, ranging from 2% to 45%, as determined by computed tomography or magnetic resonance imaging. This report describes the case of a 74-year-old female patient referred for a finding on magnetic resonance imaging of a unilocular cystic lesion in the pancreas tail. Based on the cyst’s size and its unclear nature, the patient was subjected to a repeat EUS at our institution, which showed an anechoic 35 × 20-mm finely septated lesion in the pancreatic tail. To help determine the nature of the cyst, EUS-guided needle-based confocal laser endomicroscopy (EUS-nCLE) was used because of its ability to visualize the cyst wall mucosal layer to a micrometer resolution. EUS-nCLE of the cyst wall showed an intersecting network of vessels, with background arrangement of gray oval structures and at times background arrangement of dark lobular structures. The findings were not consistent with a mucinous pancreas cyst, serous cystadenoma, or cystic neuroendocrine tumor. As for the NGS, the cyst fluid was positive for both KRAS and PIK3CA pathogenic mutations. After the patient’s distal pancreatectomy, histologic examination of the lesion entirely revealed a vascular malformation. The lesion did not have a distinct wall and was surrounded by fat and pancreas tissue. This vascular malformation is a form of lymphangioma. Lymphangiomas of the pancreas are rare, accounting for 0.2% of all pancreatic lesions. Targeted NGS performed at our institution on the surgical specimen showed absence of KRAS and PIK3CA mutations, suggesting an erroneous or false-positive initial analysis of the cyst fluid. The gray oval structures observed during EUS-nCLE correspond to adipocytes marking part of the cyst border. The dark lobular structures (coffee beans) observed during EUS-nCLE correspond to pancreatic acini marking another part of the cyst border. When these EUS-nCLE patterns are observed in a pancreas cystic lesion in the absence of any epithelial pattern, close follow-up with cross-sectional imaging should be considered instead, especially if the lesion is in a pancreas location that entails major surgery.

27 November 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
SHSouad Bou Harb
Souad Bou Harb
YZYoussef Zougheib
Youssef Zougheib
AMAyah Matar
Ayah Matar
RMReem Mansour
Reem Mansour
ZKZeina Adnan Kanafani
Zeina Adnan Kanafani
Staphylococcus lugdunensis (SL) belongs to the group of coagulase negative Staphylococci (CoNS). SL infections may have a more virulent course compared to other CoNS, bearing resemblance to infections caused by S. aureus (SA). This study aims to investigate the clinical characteristics of SL infections at a tertiary care center in Lebanon. We enrolled all patients presenting from 2017 to 2021 with positive cultures for SL from four clinical sites (urine, respiratory, wound, and blood). We then selected controls with SA matched 1:1 by site of infection. Since CoNS is not a well-described respiratory pathogen, CoNS were only matched to urine, wound, and blood. Patients who were deemed to have colonization were excluded. We determined the risk factors and outcomes associated with SL infections compared to SA and CoNS infections. We then identified predictors of mortality in the SL cohort. We identified 101 patients with SL infection, who were matched to 103 patients with SA and 97 patients with CoNS. Most SL isolates were obtained from wound samples (72%), followed by urine (16%), blood (8%) and sputum (4%). Compared to SA, SL patients were less likely to be admitted to the hospital for more than 6 days within the past 30 days (8% vs. 31%; p< 0.01). On the other hand, compared to CoNS, patients in the SL cohort were more likely to have a history of endocarditis (6% vs. 0%; p=0.01). There were no other significant differences between baseline characteristics of SL, SA, and CoNS patients. As far as outcomes, compared to the SA group, patients with SL were more likely to develop renal insufficiency (odds ratio [OR] 4.9; 95% confidence interval [CI] 1.0-23.5) and less likely to have persistent bacteremia (OR 0.5; 95% CI 0.4-0.6). No difference in outcomes was observed between the SL and CoNS cohorts. The mortality rate among SL patients was 8%. The predictors of mortality in this cohort are found in the table. SL appears to be more associated with patients in the community rather than the hospital setting and may be more likely to occur in patients with damaged heart valves. Chronic pulmonary disease and a blood source of infection are associated with a fatal outcome in SL patients. All Authors: No reported disclosures